Probiotics and inflammatory bowel disease: is there a scientific rationale?
about
Probiotics for induction of remission in Crohn's diseaseMaintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineDiet therapy for inflammatory bowel diseases: The established and the newAdherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epitheliaPostsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.Alternative medicines as emerging therapies for inflammatory bowel diseases.Probiotics in inflamatory bowel disease.Dietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitisModulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractionsNovel therapies in the treatment of ulcerative colitis.Probiotics in the management and prevention of atopy.Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future.Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.Evaluation of new therapies for inflammatory bowel disease.Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.Probiotics: The scientific evidence in the context of inflammatory bowel disease.Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's diseaseHost-flora interactions in inflammatory bowel disease.Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression.Adherent-invasive Escherichia coli target the epithelial barrier.Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran.Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells.Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation.A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow.Probiotics for Crohn's disease: what have we learned?Effects of probiotic on intestinal mucosa of patients with ulcerative colitis.Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials.Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice.Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.
P2860
Q24242115-093DE827-FC0F-409E-A76F-CC8413734637Q24685766-3EA62D2A-F626-493E-BE09-1CF1DE02F392Q26768564-153EC8B9-AA77-48A0-9EF8-0818A4389992Q33497020-943C50AF-EC2B-4162-BBB3-06DF8D8C435EQ33535970-6A983656-28E6-4EF4-9C4C-8A324026A092Q33795727-591D38E0-BE5B-4CC5-AEB8-8ED8504AE4BBQ34069427-56AB9A92-2119-49E8-941F-093842288FEAQ34219375-5D256FDA-FBB3-4170-AE16-492C13E0F108Q34257931-0FDF6EB0-5014-40B0-ABE5-49D27E5E15C9Q34357982-0FBD55E8-5101-4A59-845E-13B77C0FF1BFQ34481535-EC0CE182-5D86-48AE-821C-C99DC11897BAQ34665519-303131F9-8910-42A7-A971-3D7E4357C6BAQ34820458-54B90F6E-280C-4C9B-959D-69031600F4C4Q35059717-D89F0CFE-060C-4103-AAFB-EB8371F866D9Q35199488-A0442925-D9B9-404D-A2E4-2ECE3B084D6EQ35216827-4C94E6D9-9D5A-43C4-8F2C-CF75214B8B54Q35594940-3E713488-F17C-4164-815F-BE0130952603Q35595783-0463A154-4331-4467-9DFC-0C2B4499CDADQ35637895-B1A22FA5-9270-4790-B8E4-BDDC053A403DQ35760252-31EC7B0A-9CA5-40B0-8914-72FA4661876EQ35787630-AC096969-4DF5-4650-A6C5-0DA0353E672DQ35890738-81987A3A-5FC2-4A87-A575-F653CC031B42Q36446276-64C619C1-00BC-45CB-8781-7D346325D71BQ37290683-50A43370-69B4-46B0-B72C-9DD779997B8EQ37320010-7B0F98F1-370E-4A8D-A104-42ABA18005E0Q37521881-BDD2CA32-192E-45ED-8559-2E75CC20E7FDQ39782336-CAD6D4F8-3A2B-482B-B394-1C94143A4B59Q40338024-0C8CE451-989D-4896-ABB9-D077AF0317B7Q40414006-F7846883-CB90-4965-933E-B6318E915168Q41877251-0955760B-A75D-4B96-9FCD-40358EB82632Q42687364-0A61CACD-466B-41BD-8E1A-31911815E521Q42844641-FFD612E1-8298-40B5-B803-A9350556ECF6Q43159889-CD1A39DB-E5D2-4D54-B163-D797C6FB83F7Q45285907-793A3C95-146E-4075-AE81-D50B1A2E5CF2Q50887663-0C0C29B9-4634-4013-A462-13D1229C4CF8Q54423059-9EBB6033-ACE7-4385-AAB2-DBFB58F6C826Q54431152-E0079B7C-EFA5-4D95-AFC7-A03715A7DE14
P2860
Probiotics and inflammatory bowel disease: is there a scientific rationale?
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@ast
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@en
type
label
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@ast
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@en
prefLabel
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@ast
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@en
P2860
P1476
Probiotics and inflammatory bowel disease: is there a scientific rationale?
@en
P2093
Shanahan F
P2860
P304
P356
10.1097/00054725-200005000-00007
P577
2000-05-01T00:00:00Z